Qube Research & Technologies (QRT)
VRTX icon

Qube Research & Technologies (QRT)’s Vertex Pharmaceuticals VRTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.66M Sell
8,200
-16,900
-67% -$7.88M ﹤0.01% 1823
2025
Q4 		$11.4M Buy
25,100
+6,600
+36% +$2.84M 0.01% 1263
2025
Q3 		$7.25M Buy
18,500
+7,000
+61% +$2.93M 0.01% 1517
2025
Q2 		$5.12M Buy
11,500
+9,400
+448% +$4.33M 0.01% 1681
2025
Q1 		$1.02M Sell
2,100
-22,700
-92% -$10.6M ﹤0.01% 2250
2024
Q4 		$9.99M Sell
24,800
-25,300
-50% -$11.7M 0.01% 1089
2024
Q3 		$23.3M Buy
50,100
+49,800
+16,600% +$23.9M 0.03% 604
2024
Q2 		$141K Buy
+300
New +$130K ﹤0.01% 2526
2023
Q4 		– Sell
-9,600
Closed -$3.34M – 4777
2023
Q3 		$3.34M Buy
+9,600
New +$3.36M 0.01% 1129

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return